Hearing Loss Trial, Recruiting NCT07039435 Sponsor: NYU Langone Health Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07039435
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have no known structural or physical abnormalities in either ear
  • People who speak English
  • People who are planning to receive a cochlear implant in one ear, or who have already had one placed but it has not yet been switched on
  • People who have normal hearing or only very slight hearing loss in the opposite ear to the one receiving the implant

Who may not be able to join:

  • People who are under 18 years of age
  • People who have a documented structural or physical abnormality in the ear receiving the implant
  • People who do not speak English
  • People who have more than very slight hearing loss in the opposite ear to the one receiving the implant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mario A. Svirsky, PhD, NYU Langone Health

Phone: 646-284-2457

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 January 2024
Est. completion
31 July 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Bilateral speech perception as measured by Bamford-Kowal-Bench (BKB-SIN) speech-in-noise score while using standard 188 Hz Frequency-Allocation Table (FAT); Bilateral speech perception as measured by BKB-SIN speech-in-noise score while using standard 188 Hz FAT; Bilateral speech perception as measured by BKB-SIN speech-in-noise score while using standard 188 Hz FAT; Bilateral speech perception as measured by BKB-SIN speech-in-noise score while using standard 188 Hz FAT; Bilateral speech perception as measured by BKB-SIN speech-in-noise score while using standard 188 Hz FAT; Bilateral speech pe...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov